Catalyst Wire Dossier Catalyst Wire Dossier

Kamada anti-SARS-CoV-2 therapy

· Kamada, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kamada anti-SARS-CoV-2 therapy, covering 2021-01-05 to 2021-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19 [Phase 1, Phase 2]

See pricing